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LETTERS TO THE EDITOR
Residents with military obligation face discrimination
This is the time of year when surgical residents interested in a
career in vascular surgery interview for fellowship positions, and
vascular fellows about to finish their training, interview for practice
opportunities. Naturally, the interviewing program directors and
the department chairmen try to get the best residents or fellows.
Unfortunately, in this process, I have noticed that a subtle bias
has developed in some programs against candidates who have a
future military obligation. These candidates are recipients of mili-
tary stipends and are required to serve in the reserves after com-
pleting their training. It is very rare that they are called to serve a
tour of duty while they are in training. Should they be called, albeit
rarely, it can cause an inconvenience to the program. The incon-
venience and stress caused to the individual and his family is
manifold. I speak from personal experience, having served in
Kosovo, Afghanistan, and Iraq in the last 4 years while working as
a vascular surgeon in a civilian group practice.
Every program is aware that it cannot discriminate on the basis
of age and ethnicity and therefore asking about these is inappro-
priate and illegal. I would like to remind all the program directors
and department chairmen that discriminating on the basis of
military service or obligation is also illegal. In my opinion, it is also
unethical and unpatriotic. I hope that after reading this letter,
candidates will not be asked about their military affiliation, so that
there is not even an appearance of bias. I am sure that the commu-
nity of vascular surgeons, many of whom are veterans themselves,
want the best care for our injured men and women in the battle-
field.
Narayan Deshmukh, MD
Colonel (retired), US Army Reserve
Sayre, Penn
doi:10.1016/j.jvs.2005.04.002
Regarding “Compelling nature of arterial
manifestations in Behçet disease”
I read with great interest the report from Iscan et al.1 My
experience supports the authors’ conclusions concerning arterial
complications of Behçet disease. I would like to point out, how-
ever, that this disease should be reported as Adamantiades-Behçet
disease. This is because it was the Greek ophthalmologist Benedict
Adamantiades (1875-1962) who in contemporary times first orally
presented this disease at the Medical Society of Athens in 1930,
and a year later he published it. 2 Six years later, the Turkish
dermatologist Hulusi Behçet (1889-1948), independently from
Adamantiades, described the disease for the second time. 3
I have three questions for the authors. First, I have found it
difficult to delineate normal from diseased artery segments when
selecting a site for anastomosis in these patients, and I wonder how
the authors advise doing this. Second, because pseudoaneurysms
occur at the anastomoses of both prosthetic and vein grafts in these
patients, I believe that endovascular reconstructionmay be safer, as
has been described by others.4-6 Would the authors comment on
the role of endovascular grafts in patients with Adamantiades-
Behçet disease? Third, when a bypass is needed for limb salvage
after arterial thrombosis, reinforcement of the anastomosis by
wrapping it with a synthetic (Dacron [DuPont, Wilmington, Del]
or polytetrafluoroethylene) band would offer a theoretical support
against the development of pseudoaneurysms. Would the authors
comment on this?
Athanasios D. Giannoukas, MSc, MD, PhD, EBSQVASC
Division of Vascular Surgery
University Hospital of Larissa
University of Thessaly Medical School
Larissa, Greece
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Reply
Despite such letters to the editor that typically appear after any
scientific article on Behçet’s disease, the medical literature widely
recognizes the appropriateness of eponym “Behçet.” A simple
search in Medline retrieves more than 5,000 references for Behçet
or Behçet’s disease, compared with only about 70 for Adamantia-
des-Behçet disease. Many of the latter are letters written in a quite
similar manner and concerned mainly with the eponym “Behçet”
rather than scientific contribution.
The fact is, it was Dr Hulusi Behçet who first recognized the
syndrome, correctly defined its characteristics, and described the
classic triad that is still a worldwide guide in today’s modern
medicine.1 He put special emphasis on the recurrent aphthous
stomatitis (ie, oral ulcerations) that is considered the universal
hallmark of the disease and a key to diagnosis. The International
Society for Behçet’s Disease acknowledges his contribution in the
official web site as follows:
Origins of the disease:
A Greek physician called Hippocrates, writing in 500 BC,
described a cluster of symptoms that seems to be that of Behçet’s
disease. However, although various researchers wrote about this
disorder after that time, it wasn’t until 1937 that it got its name. A
Turkish dermatologist called Hulusi Behçet published an article in
a German medical journal in which he said he had noticed a
characteristic set of symptoms in some of his patients which he
thought all belonged to a specific disorder. He listed the ‘classical’
set of symptoms of mouth and genital ulcers with eye inflammation
that identified it. Since then, other symptoms have been added to
the original list, but the name of Behçet has remained.2
After Hippocrates’ descriptions as an endemic disease in the
Middle East, very few observations of the unique symptoms ap-
peared in the medical literature until the early 1900s. In the
beginning, this complex was considered to be a manifestation of
syphilis, but in 1937, Behçet proposed a separate disease entity that
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